Literature DB >> 12225493

Duration of untreated psychosis and its correlates in first-episode psychosis in Finland and Spain.

O Kalla1, J Aaltonen, J Wahlström, V Lehtinen, I García Cabeza, M González de Chávez.   

Abstract

OBJECTIVE: To examine the association of duration of untreated psychosis (DUP) with early course characteristics in first-episode psychosis in Finland and Spain.
METHOD: Eighty-six patients from Finland (49) and Spain (37) were evaluated on various early course characteristics.
RESULTS: The mean value of DUP was 4.0 months (median 2 months) for the Finnish patients and 9.9 months (median 2 months) for the Spanish ones. In both groups, long DUP was associated with insidious onset, poor global functioning, and laboral incapability. Among the Finnish patients exclusively, long DUP correlated with a weak earlier social network, instability of professional identity, long duration of prodromal symptoms, psychological dependency on the family, and criticism by the parents of the patient. Among the Spanish patients only, longer DUP was associated with more severe positive symptoms at admission.
CONCLUSION: There are universal psychosocial factors influencing DUP, but also cultural differences may have an impact on the treatment delay.

Entities:  

Mesh:

Year:  2002        PMID: 12225493     DOI: 10.1034/j.1600-0447.2002.02302.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  20 in total

Review 1.  Review of the operational definition for first-episode psychosis.

Authors:  Nicholas J K Breitborde; Vinod H Srihari; Scott W Woods
Journal:  Early Interv Psychiatry       Date:  2009-11       Impact factor: 2.732

Review 2.  Are the effects of duration of untreated psychosis socially mediated?

Authors:  Ross M G Norman
Journal:  Can J Psychiatry       Date:  2014-10       Impact factor: 4.356

3.  Associations between duration of untreated psychosis and domains of positive and negative symptoms.

Authors:  Michael L Birnbaum; Claire Ramsay Wan; Beth Broussard; Michael T Compton
Journal:  Early Interv Psychiatry       Date:  2015-07-14       Impact factor: 2.732

Review 4.  Medication-free research in early episode schizophrenia: evidence of long-term harm?

Authors:  John R Bola
Journal:  Schizophr Bull       Date:  2005-10-27       Impact factor: 9.306

5.  The impact of family experience on the duration of untreated psychosis (DUP) in Hong Kong.

Authors:  Eric Yu-Hai Chen; Eva Lai-Wah Dunn; May Yin-King Miao; Wai-Song Yeung; Chi-Keung Wong; Wah-Fat Chan; Ronald Yuk-Lun Chen; Ka-Fai Chung; Wai-Nang Tang
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2005-05       Impact factor: 4.328

6.  Family-level predictors and correlates of the duration of untreated psychosis in African American first-episode patients.

Authors:  Michael T Compton; Sandra M Goulding; Tynessa L Gordon; Paul S Weiss; Nadine J Kaslow
Journal:  Schizophr Res       Date:  2009-10-14       Impact factor: 4.939

7.  Health services determinants of the duration of untreated psychosis among African-American first-episode patients.

Authors:  Michael T Compton; Claire E Ramsay; Ruth S Shim; Sandra M Goulding; Tynessa L Gordon; Paul S Weiss; Benjamin G Druss
Journal:  Psychiatr Serv       Date:  2009-11       Impact factor: 3.084

8.  Mental health laws that require dangerousness for involuntary admission may delay the initial treatment of schizophrenia.

Authors:  Matthew M Large; Olav Nielssen; Christopher James Ryan; Robert Hayes
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2007-11-30       Impact factor: 4.328

Review 9.  Evidence for a relationship between the duration of untreated psychosis and the proportion of psychotic homicides prior to treatment.

Authors:  Matthew Large; Olav Nielssen
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2007-10-24       Impact factor: 4.328

Review 10.  Social networks, support and early psychosis: a systematic review.

Authors:  C Gayer-Anderson; C Morgan
Journal:  Epidemiol Psychiatr Sci       Date:  2012-07-26       Impact factor: 6.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.